Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urologic cancer.

G P Murphy1

  • 1State University of New York, Buffalo 14214.

Cancer
|October 15, 1988
PubMed
Summary
This summary is machine-generated.

Smoking cessation is key for preventing urinary tract cancers. Lifestyle changes like reduced fat intake and weight loss can also lower cancer risk. Advances in diagnostic imaging and biomarkers are improving detection and management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two mechanisms for growth inhibition by elevated transport of sugar phosphates in Escherichia coli.

Journal of general microbiology·1992
Same author

Revision in American Cancer Society recommendations for the early detection of colorectal cancer.

CA: a cancer journal for clinicians·1992
Same author

The association of benign prostatic hyperplasia and cancer of the prostate.

Cancer·1992
Same author

Relapsing disease.

Cancer·1992
Same author

The relationship of prostate-specific antigen to digital rectal examination and transrectal ultrasonography. Findings of the American Cancer Society National Prostate Cancer Detection Project.

Cancer·1992
Same author

Prostate-specific antigen levels in 1695 men without evidence of prostate cancer. Findings of the American Cancer Society National Prostate Cancer Detection Project.

Cancer·1992
Same journal

Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

Cancer·2026
Same journal

Proliferative ecotype determines lethal prognosis and therapeutic benefit in urothelial carcinoma.

Cancer·2026
Same journal

Reply to "Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer".

Cancer·2026
Same journal

Pediatric cancer survival in the United States from 2001 to 2021.

Cancer·2026
Same journal

Updates on intratumoral therapies in melanoma.

Cancer·2026
Same journal

Correction to "Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025".

Cancer·2026
See all related articles

Area of Science:

  • Urology
  • Oncology
  • Diagnostic Imaging

Background:

  • Urinary tract carcinomas present significant health challenges.
  • Lifestyle factors, particularly smoking, are strongly linked to increased risk.
  • Advances in medical technology have introduced new diagnostic and staging tools.

Purpose of the Study:

  • To review current strategies for cancer prevention and risk reduction in urinary tract carcinomas.
  • To highlight advancements in diagnostic techniques for genitourinary cancers.
  • To discuss the role of biomarkers in the detection and management of these cancers.

Main Methods:

  • Review of recent assessments on smoking prevalence in bladder cancer patients.
  • Evaluation of diagnostic imaging modalities including ultrasonography, CT scanning, and MRI.

Related Experiment Videos

  • Discussion of emerging biomarkers such as prostate-specific antigen (PSA) and flow cytometry.

    • Main Results:

    • Smoking cessation remains the most effective preventive measure for urinary tract cancers.
    • Advanced imaging techniques (ultrasound, CT, MRI) have improved the evaluation of renal masses and tumor staging.
    • Prostate-specific antigen (PSA) is a widely accepted biomarker for prostate cancer detection and monitoring.

    Conclusions:

    • Prevention through lifestyle modifications like smoking cessation and dietary changes is crucial.
    • Technological advancements in diagnostic imaging and molecular markers are enhancing early detection and patient management.
    • Continued research into biologic markers holds promise for more accurate diagnosis and prognosis of genitourinary cancers.